tetano
Editor, Senior Moderator
J Pediatric Infect Dis Soc. 2020 Mar 19;9(Supplement_1):S19-S23. doi: 10.1093/jpids/piaa007.
Nontraditional Uses of Live Attenuated Influenza Vaccine: School-Located Influenza Vaccination.
Weinberg GA[SUP]1[/SUP].
Author information
Abstract
Immunization against influenza continues to be the best method of preventing influenza infection in children, and additionally, indirectly helping to lower disease in adults, given the role of children as "spreaders" of influenza to the community at large. An increasing evidence base exists for the use of school-located influenza vaccination (SLIV) programs to increase the influenza vaccination rates among children. Live, attenuated influenza vaccine (LAIV) has unique characteristics that make it useful for SLIV programs, including ease of immunization without needles, faster delivery, and in many (but not all) years, good vaccine effectiveness. Reviewed herein are results of selected published trials as well as guidance on planning a successful SLIV program.
? The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
KEYWORDS:
LAIV; SLIV; attenuated influenza vaccine; live; school-based immunization; school-located influenza vaccination
PMID:32191311DOI:10.1093/jpids/piaa007
Nontraditional Uses of Live Attenuated Influenza Vaccine: School-Located Influenza Vaccination.
Weinberg GA[SUP]1[/SUP].
Author information
Abstract
Immunization against influenza continues to be the best method of preventing influenza infection in children, and additionally, indirectly helping to lower disease in adults, given the role of children as "spreaders" of influenza to the community at large. An increasing evidence base exists for the use of school-located influenza vaccination (SLIV) programs to increase the influenza vaccination rates among children. Live, attenuated influenza vaccine (LAIV) has unique characteristics that make it useful for SLIV programs, including ease of immunization without needles, faster delivery, and in many (but not all) years, good vaccine effectiveness. Reviewed herein are results of selected published trials as well as guidance on planning a successful SLIV program.
? The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
KEYWORDS:
LAIV; SLIV; attenuated influenza vaccine; live; school-based immunization; school-located influenza vaccination
PMID:32191311DOI:10.1093/jpids/piaa007